BLFS - Company ID 0000834365
The table below shows BIOLIFE SOLUTIONS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$491.00K | $1.73M | -$4.47M | -$2.71M | -$7.92M | $1.82M |
| Capital expenditure | $167.00K | $175.00K | - | $3.29M | $1.46M | $1.72M |
| Investing cash flow | -$1.83M | -$27.18M | -$221.00K | $2.93M | -$2.27M | -$4.43M |
| Dividends paid | - | - | - |
BIOLIFE SOLUTIONS INC reported operating cash flow of $20.11M for fiscal year 2025. That is up 138.6% from $8.43M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$4.33M (FY 2016) to $20.11M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$7.89M | -$2.99M | -$952.00K | -$562.00K | -$181.00K | $1.22M |